These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9692003)

  • 1. Pulmonary involvement of Gaucher's disease in children: a common presentation in Saudi Arabia.
    Banjar H
    Ann Trop Paediatr; 1998 Mar; 18(1):55-9. PubMed ID: 9692003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary pathology in Gaucher's disease.
    Amir G; Ron N
    Hum Pathol; 1999 Jun; 30(6):666-70. PubMed ID: 10374775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Course of a case of Gaucher's disease type 1 treated over a year with glucocerebrosidase (Cérédase)].
    Belmatoug N; Azorin M; Huten D; de Villemeur TB; Carbon C
    Rev Med Interne; 1993; 14(10):996. PubMed ID: 8009089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enzyme therapy in children with severe forms of Gaucher's disease].
    Zeman J; Hrebícek M; Vepreková L; Kytnarová J; Houstková H; Malinová V; Hodanová K; Poupĕtová H; Ledvinová J; Hoza J
    Cas Lek Cesk; 1997 Feb; 136(3):95-7. PubMed ID: 9221177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistence of pulmonary lesions in a 6-year-old boy with type I Gaucher's disease treated by alglucerase since the age of 20 months].
    Versteegh C; Avni F; Cuvelier P; Ferster A
    Arch Pediatr; 1998 Dec; 5(12):1341-3. PubMed ID: 9885741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
    Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
    Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung involvement and enzyme replacement therapy in Gaucher's disease.
    Goitein O; Elstein D; Abrahamov A; Hadas-Halpern I; Melzer E; Kerem E; Zimran A
    QJM; 2001 Aug; 94(8):407-15. PubMed ID: 11493717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceredase dosing concerns for Gaucher's disease.
    Moscicki RA; van Heek J
    Am J Med; 1994 Oct; 97(4):402-3. PubMed ID: 7942949
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase.
    Mistry PK; Davies S; Corfield A; Dixon AK; Cox TM
    Q J Med; 1992 Jul; 83(303):541-6. PubMed ID: 1484931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study.
    Damiano AM; Pastores GM; Ware JE
    Qual Life Res; 1998 Jul; 7(5):373-86. PubMed ID: 9691718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
    J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alglucerase. A review of its therapeutic use in Gaucher's disease.
    Whittington R; Goa KL
    Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtotal splenectomy for Gaucher's disease: a follow-up study.
    Morgenstern L; Verham R; Weinstein I; Phillips EH
    Am Surg; 1993 Dec; 59(12):860-5. PubMed ID: 8256944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher's disease at a national referral hospital.
    Murila F; Rajab JA; Ireri JM
    East Afr Med J; 2008 Sep; 85(9):455-8. PubMed ID: 19537419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher's disease in Lithuania: its diagnosis and treatment.
    Kleinotienė G; Tylki-Szymanska A; Czartoryska B
    Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological features in Gaucher's disease during enzyme replacement therapy.
    Ono H; Fujiwara M; Ito K; Ueda H; Mizoguchi N; Sakura N
    Acta Paediatr; 2001 Feb; 90(2):229-31. PubMed ID: 11236058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.
    MacKenzie JJ; Amato D; Clarke JT
    CMAJ; 1998 Nov; 159(10):1273-8. PubMed ID: 9861225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzyme substitution in Gauscher disease].
    Steensberg J; Nielsen KG; Brandt NJ
    Ugeskr Laeger; 1998 Jun; 160(26):3900-3. PubMed ID: 9656829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in Gaucher's disease.
    Pastores GM; Miller A
    Lancet; 1998 Aug; 352(9127):580. PubMed ID: 9716094
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gaucher's disease in children: first clinical signs, natural course and benefits of enzyme replacement therapy].
    Caubel I; Billette de Villemeur T; Belmatoug N;
    Arch Pediatr; 2003 Aug; 10(8):681-8. PubMed ID: 12921999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.